The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...

Water levels, plant life, and wildlife behavior shift constantly. What looks quiet on the surface often reflects ...

A viral story has Americans ditching cheese upon discovering that ~90% contains a genetically engineered enzyme (FPC) ...

In this week’s edition of The Prototype, we look at building a virtual fusion power plant, a major quantum breakthrough, AI ...

Insmed’s Brinsupri blew past consensus estimates in its first full quarter on the market. Elsewhere, J&J inked pharma’s ...

We have to protect ourselves,” Easton planning officials said as they consider expanding a city ordinance to cover data ...

According to Bayer, vaccine manufacturers including Pfizer, BioNTech, and Moderna copied technology pioneered by Monsanto in ...

A nuclear power plant in western Japan is working "as normal", its parent company said on Tuesday (January 6), after an earthquake with a preliminary magnitude of 6.2 hit its premises in Japan's ...

Nearly 15 years after one of the world’s greatest nuclear disasters in Fukushima, Japan’s push to restart nuclear power has ...

On Tuesday, top executives from several multinational companies convened in Wuxi, Jiangsu province, to commend the region's robust development environment, express a strong commitment to deepening ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles ...

Eli Lilly has been a dominant force in the GLP-1 market, and that looks set to continue. Pfizer's acquisitions haven't paid off yet and the company is still struggling to grow its sales. The two ...